Analyzing Genetic Differences Between Sporadic Primary and Secondary/Tertiary Hyperparathyroidism by Targeted...

Area of Science:

• Nephrology
• Endocrinology
• Molecular Genetics

Background:

• Secondary hyperparathyroidism (SHPT) involves elevated parathyroid hormone due to kidney dysfunction.
• Tertiary hyperparathyroidism (THPT) often arises from prolonged SHPT.
• The genetic basis of uremic hyperparathyroidism remains largely unknown, contrasting with primary hyperparathyroidism (PHPT).

Purpose of the Study:

• To investigate and differentiate the genetic alterations in primary hyperparathyroidism (PHPT) versus secondary/tertiary hyperparathyroidism (SHPT/THPT).
• To identify candidate pathogenic mutations contributing to the development of different forms of hyperparathyroidism.

Main Methods:

• Targeted next-generation sequencing of hyperparathyroidism-associated genes.
• Analysis of DNA extracted from parathyroid tissues of patients with PHPT, SHPT, and THPT.
• Comparison of mutation frequencies and types between patient groups.

Main Results:

• Twenty-six variants in 19 genes were identified as potential pathogenic mutations in PHPT or SHPT/THPT.
• MEN1, ASXL3, EZH2, and MTOR were frequently mutated genes.
• Mutations were significantly more common in PHPT (64%) than in SHPT/THPT (21%).
• Parathyroid adenomas showed a higher mutation burden and included known driver mutations (CCND1, CDC73, MEN1) compared to parathyroid hyperplasia.

Conclusions:

• Molecular genetic abnormalities in SHPT/THPT are distinct from those observed in PHPT.
• These findings provide insights into the molecular pathogenesis of uremic hyperparathyroidism.
• Further research into these genetic differences may aid in understanding and potentially treating uremic HPT.